Cancer/Malignancies

CROI 2013: Statins for People with HIV -- How Sweet Is It?

Statins may help reduce co-morbid conditions such as cardiovascular disease and lower mortality for some people with HIV, but with a possible trade-off of higher diabetes risk, according to a series of studies presented and discussed at 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta.

alt

Read more:

CROI 2013: HIV and Aging -- Are People with HIV at Greater Risk for Heart Disease and Cancer? [VIDEO]

Keri Althoff from the VA Medical Center and George Washington University Medical School described findings from a study looking at risk of non-AIDS conditions such as cardiovascular disease and cancer at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) this month in Atlanta.

alt

Read more:

CROI 2013: Cancer Incidence After Starting Antiretroviral Therapy [VIDEO]

Rates of AIDS-related cancers start to fall not long after initiation of antiretroviral therapy (ART), but non-AIDS cancers rise with increasing time on therapy, according to study findings presented last week at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.

alt

Read more:

CROI 2013: HIV+ Men at Increased Risk for Co-morbid Conditions Regardless of Age

 Men with HIV in a large cohort of U.S. veterans were more likely to develop cardiovascular disease, end-stage kidney disease, and certain cancers compared with HIV negative people, but not at earlier ages, according to a report presented at the 20th Conference on Retroviruses and Opportunistic Infections this month in Atlanta.

alt

Read more:

People with HIV Have Higher Rates of Non-AIDS Malignancies, Skin Cancer

The incidence of non-AIDS-defining cancers has increased among people with HIV in the era of effective antiretroviral treatment, including malignancies caused by viruses such as human papillomavirus (HPV), and squamous cell non-melanoma skin cancer, according to 2 recently published studies.alt

Read more: